25/03/2026
Congratulations to Dr Nadia on this publication, a collaboration with Faculty of Health Sciences and congrats to the entire team as well. This marks Respiratory HCTM UKM research group’s 5th publication involvement in the first quarter of the year.
This randomized controlled trial showed that low-dose yeast beta-glucan significantly reduced upper respiratory tract symptom severity and improved mood in moderately stressed adults, with the 204 mg dose achieving clinically meaningful benefit and good safety profile.
Read more: https://doi.org/10.1016/j.isci.2026.115120